@8BitJpeg@grok@peptidepedia I didnt know Grok could do that!
Very funny!
I dont really need new customers, I just was gobsmacked by Peptipedias prices.
I've already worked out a way around the budgets bullshit 30% tax on trusts. I will move my trust into a normal company structure... And 1 week before the end of financial year I will use a personal abn of each person I previously distributed income to... And just invoice the co
There is an epidemic of lilac cap R30s failing sterility. We have 3 confirmed from different vendors ; Alice TFC, JEEP and SSP. JEC have also sold lilac cap R30s and a vendor ZJ too. I only have a pic of the JEC kit which hasn't had a sterility test done .
Alice TFC kits are being resold with complementary filters
@BumpMemeDev Shit my spine out has me dead. Aussie customs is strict but not impossible some vendors ship there successfully. Peptides aren't regulated for research use, but personal import is grey. I’ve got Australia friendly vendors inside my Telegram group link Your spine should be fine
I’m 35 and take
- Retatrutide for effective weight loss
- Tesamorelin for visceral fat loss via GH release
- Kisspeptin for boosting LH/FSH and testosterone
- BPC-157 for accelerated tissue healing and repair
- MOTS-c for enhanced mitochondrial metabolism and insulin sensitivity
- DSIP for deeper, restorative sleep
Retatrutide might be the most exciting weight loss drug in development right now, and the Phase 3 results are backing up the hype. But will it come to Australia?
Eli Lilly's TRIUMPH-4 trial showed an average of 28.7% body weight loss at 68 weeks. That's roughly 32 kg gone. For context, semaglutide (Ozempic/Wegovy) delivers around 15%.
The difference? Retatrutide is a "triple G" agonist. It targets GLP-1, GIP, and glucagon receptors simultaneously instead of just one or two.
More hormonal pathways, more potent appetite and metabolic effects.
Seven more Phase 3 trials are expected to report throughout 2026, covering obesity, type 2 diabetes, and sleep apnoea.
So when can Australians get it? The TGA hasn't received a submission yet. Eli Lilly is expected to file with the FDA in late 2026, and the TGA typically follows 6–18 months after FDA approval.
Realistic estimates put Australian availability around early 2029, possibly sooner if the TGA fast-tracks it, given the obesity crisis here.
Right now, 19 Australian research sites are involved in the TRIUMPH clinical trials. It's coming, just not tomorrow.
This is the one to watch.
protocolhub.com.au/peptides/retat…
@web3celebrity@HappyCanadian55@gregogallagher I paid $250 for 10mg of Reta the first time I got it and lasted 7 week next time I paid $165 for 10mg this will last 4 weeks 😂.. every things cheep in Australia
If you have literally no appetite on reta or tizepatide
News flash, you are taking too much
The goal is to remove all friction with hitting your calories (12-13 cals per pound of goal weight perf)
A quarter of Australia’s fuel comes from refineries in Singapore.
That’s why I’m here, working with our international partners to keep fuel flowing for Australians.
Because when things are uncertain around the world, strong relationships with our neighbours matter more than ever.
🇦🇺🦘the land down under finally got a domestic peptide vendor. reta, ghk-cu, semax, selank, BPC-157, epitalon, NAD+ and soon they're stocking intranasal bromantane as well
they've been around for a while operating mainly on telegram, but now they've got a website. great products, great people. most orders arrive next day, everything's shipped express.
right now they're running an easter sale for 20% off with code EASTER20, and with code BASED you get free shipping
reuplabsaus.com/?ref=BASED